SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-20-000011
Filing Date
2020-05-13
Accepted
2020-05-13 12:14:06
Documents
86
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20200331x10q.htm 10-Q 1522283
2 EX-10.2 veru-20200331xex10_2.htm EX-10.2 37038
3 EX-10.3 veru-20200331xex10_3.htm EX-10.3 38997
4 EX-31.1 veru-20200331xex31_1.htm EX-31.1 15600
5 EX-31.2 veru-20200331xex31_2.htm EX-31.2 15825
6 EX-32.1 veru-20200331xex32_1.htm EX-32.1 11491
  Complete submission text file 0000863894-20-000011.txt   7729854

Data Files

Seq Description Document Type Size
7 EX-101.INS veru-20200331.xml EX-101.INS 1795146
8 EX-101.SCH veru-20200331.xsd EX-101.SCH 69050
9 EX-101.CAL veru-20200331_cal.xml EX-101.CAL 90990
10 EX-101.DEF veru-20200331_def.xml EX-101.DEF 190270
11 EX-101.LAB veru-20200331_lab.xml EX-101.LAB 489821
12 EX-101.PRE veru-20200331_pre.xml EX-101.PRE 398171
Mailing Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127
Business Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 20871836
SIC: 2834 Pharmaceutical Preparations